Lisa Baldwin
Internal Medicine · Tulsa, OKNPI 1508903824
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 51 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 22 manufacturers, the largest accounting for just 11.9% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2020 at $334 and has fallen 87.2% since, to $43 in 2023.
Across 51 payments — averaging $16.94 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AstraZeneca$102
- Astellas Pharma US Inc$94
- Novartis$83
- Amgen$73
- Ipsen Biopharmaceuticals, Inc$71
- Johnson & Johnson$61
- plus $379 from 16 others
What the payments were for
- Food & beverage$864100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AstraZeneca | 6 | $102 |
| Astellas Pharma US Inc | 5 | $94 |
| Novartis | 5 | $83 |
| Amgen | 5 | $73 |
| Ipsen Biopharmaceuticals, Inc | 3 | $71 |
| Johnson & Johnson | 3 | $61 |
| Daiichi Sankyo Inc. | 3 | $54 |
| Genentech USA, Inc. | 3 | $52 |
| Seagen Inc. | 3 | $45 |
| Pharmacyclics LLC, An Abbvie Company | 2 | $30 |
| Clovis Oncology, Inc. | 2 | $29 |
| Exact Sciences | 1 | $24 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $19 |
| Pharmacosmos Therapeutics Inc. | 1 | $19 |
| Blueprint Medicines Corporation | 1 | $18 |
| Karyopharm Therapeutics Inc. | 1 | $15 |
| Lilly USA, LLC | 1 | $14 |
| Kyowa Kirin, Inc. | 1 | $13 |
| Merck | 1 | $13 |
| Eisai Inc. | 1 | $12 |
| Epizyme, Inc. | 1 | $12 |
| Teva Pharmaceuticals USA, Inc. | 1 | $12 |
How this compares
$864 in reported general payments places this provider in the 65th percentile of 840 internal medicine providers in Oklahoma.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Albuterol Sulfate HfaAlbuterol Sulfate | 16 | $423 |
| Azelastine Hcl | 15 | $280 |
| Levothyroxine Sodium | 15 | $84 |
| Sertraline Hcl | 11 | $71 |
| Doxycycline Monohydrate | 12 | $65 |
Paid to pharmacies, not to this prescriber.
Other internal medicine in Tulsa
- Jesse RichardsTulsa$279K
- Madhuri LadTulsa$173K
- Stacy ChronisterTulsa$163K
- Layth Al AttarTulsa$35K
- Gerard McNultyTulsa$27K
- Peter LantzTulsa$23K
- Sudip TripathyTulsa$21K
- John RuffingTulsa$21K
- Joseph ReeseTulsa$18K
- Mark GallesTulsa$17K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.